Recent Modalities in Treatment of Telogen Effluvium: Comparative Study

July 2022 in “ Dermatologic Therapy ”

Fathia M Khattab, Areeg Rady, Shrook A Khashaba

telogen effluvium botulinum toxin A multivitamins mesotherapy terminal hair multiple follicular units Botox

TLDR Both botulinum toxin A and multivitamin mesotherapy effectively treat hair loss, with botulinum toxin A being the better single-session option.

The study "Recent modalities in treatment of telogen effluvium: Comparative study" conducted by Fathia M. Khattab, Areeg Rady, and Shrook A. Khashaba from the Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University, Egypt, aimed to evaluate the efficacy of single session botulinum toxin A injection versus multiple sessions of multivitamins mesotherapy in the treatment of telogen effluvium. The randomized clinical trial involved 24 patients with telogen effluvium, divided into two groups of 12. Group I received a single session of Botulinum toxin A injection and group II received multiple sessions of multivitamins mesotherapy injection. The study concluded that both botulinum toxin A and multivitamins mesotherapy are effective in the treatment of telogen effluvium, improving hair parameters such as terminal hair and multiple follicular units. Both treatments had minimal and well-tolerated side effects. However, a single session of botulinum toxin A was found to be a better choice than multiple mesotherapy sessions.

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

11 / 11 results

research Efficacy of Botulinum Toxin A Injection in the Treatment of Androgenic Alopecia: A Comparative Controlled Study

3 citations, January 2022 in “Journal of Cosmetic Dermatology”

Botox can effectively treat hair loss with some side effects and high cost, while LC hair serum also shows great results with fewer side effects.

research Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia

15 citations, August 2020 in “BioMed Research International”

BTA safely and effectively treats hair loss, and works better with FNS.

research The Effect of Intradermal Botulinum Toxin on Androgenetic Alopecia and Its Possible Mechanism

15 citations, April 2020 in “Journal of The American Academy of Dermatology”

Botulinum toxin injections may help treat hair loss by blocking harmful secretion in hair follicles.

research A Pilot Study to Evaluate Effectiveness of Botulinum Toxin in Treatment of Androgenetic Alopecia in Males

24 citations, January 2017 in “Journal of Cutaneous and Aesthetic Surgery”

Botulinum toxin was found to be a safe and effective treatment for male pattern baldness in a small test, but more research is needed.

research Proposing a Simpler Classification of Telogen Effluvium

21 citations, January 2016 in “Skin appendage disorders”

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

research Postpartum Telogen Effluvium

7 citations, January 2015 in “Journal of the European Academy of Dermatology and Venereology”

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

research Trichoscopy in Alopecias: Diagnosis Simplified

96 citations, January 2013 in “International Journal of Trichology”

Trichoscopy is a useful, non-invasive way to diagnose different types of hair loss.

research Mesotherapy in the Management of Hair Loss: Is It of Any Use?

25 citations, January 2010 in “International Journal of Trichology”

Mesotherapy for hair loss lacks evidence of effectiveness and safety and should not be used without further scientific support.

research Diffuse Hair Loss: Its Triggers and Management

88 citations, June 2009 in “Cleveland Clinic Journal of Medicine”

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

research Current and Novel Methods for Assessing Efficacy of Hair Growth Promoters in Pattern Hair Loss

86 citations, February 2003 in “Journal of The American Academy of Dermatology”

New methods improve how we test hair growth treatments, but challenges like slow hair changes and high costs remain.

research Telogen Effluvium: Causes, Diagnosis, and Treatment

144 citations, July 2002 in “Clinical and Experimental Dermatology”

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Related Research

4 / 4 results

research The Usefulness and Wellbeing of Tofacitinib in the Treatment of Alopecia Areata

October 2022 in “Journal of Armed Forces Medical College, Bangladesh”

Tofacitinib is effective and safe for treating alopecia areata.

research Comprehensive Review of Oral Minoxidil in Alopecia

September 2022 in “Journal of Cosmetic Dermatology”

Oral minoxidil effectively treats different types of hair loss with fewer side effects.

research Recent Modalities in Treatment of Telogen Effluvium: Comparative Study

2 citations, July 2022 in “Dermatologic Therapy”

Both botulinum toxin A and multivitamin mesotherapy effectively treat hair loss, with botulinum toxin A being the better single-session option.

research Androgenetic Alopecia in Women and Men: Italian Guidelines Adapted from European Dermatology Forum/European Academy of Dermatology and Venereology Guidelines

4 citations, December 2020 in “Giornale italiano di dermatologia e venereologia”

Italian guidelines recommend using trichoscopy for diagnosis and treatments like minoxidil for hair loss.